Parietaria judaica allergen subcutaneous immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Parietaria judaica allergen subcutaneous immunotherapy, covering 2013-11-11 to 2013-11-11. Get the full timeline:
Most recent: Clinical Trial Update: Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica [Phase 3]